Results 31 to 40 of about 63,869 (217)
Background: Polycystic Ovary Syndrome (PCOS) is clinically associated with infertility. Many women are resistant to Clomiphene Citrate and the addition of insulin sensitisers may help to overcome this challenge.
Sabraj Gill +5 more
doaj +1 more source
ABSTRACT Females who have larger bodies or obesity may be at an increased risk for experiencing infertility. Problematically, both weight or body size and infertility are stigmatized, harming quality of care. We conducted a scoping review to understand the lived experiences of patients who may be subjected to intersecting stigmas of weight and ...
Brooke J. Hebert +16 more
wiley +1 more source
Delusional Belief induced by clomiphene treatment [PDF]
We report the case of a 35 year old women who developed a complex paranoid delusion during the course of clomiphene treatment für ovulation. The psychopathology was remarkable, because after a short hypomanic period the patient was without severe ...
Grimm, Dr. Oliver, Hubrich, Dr. Petra
core
ABSTRACT Background Male preconception health remains a critically under‐addressed area of family planning. While research suggests air pollution may harm semen quality, downstream impacts on pregnancy, particularly for more vulnerable infertility treatment populations, are understudied.
Lindsey M. Russo +14 more
wiley +1 more source
The effect of clomiphene citrate on oxidative stress parameters in polycystic ovarian syndrome
This study aimed to examine the possible association between the oxidative stress parameters and clomiphene citrate resistance in polycystic ovary syndrome.
Ege, Serhat +11 more
core +1 more source
Clomiphene citrate and ovulation induction
Clomiphene can be used to treat anovulation due to hypothalamus or pituitary gland dysfunction, and it normalizes the luteal phase in stimulated patients. It can be used to estimate ovarian follicle reserve, and may be predictive of ovulation in women aged >/=35 years or with failed IVF.
Sovino, Hugo +2 more
openaire +3 more sources
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source
Comparative Study between Letrozole versus Clomiphene Citrate in Treatment of Polycystic Ovaries (PCO) [PDF]
Background: Polycystic Ovary Syndrome (PCOS) is probably the most common reason that influences females of childbearing age and regularly prompts barrenness. Aim: To compare Letrozole versus Clomiphene citrate in the treatment of Polycystic ovaries (PCOS)
Shaimaa Abdellatif +2 more
doaj +1 more source
Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?
ABSTRACT Background Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility. Hypogonadism is common in NOA patients, and normal testosterone (T) levels are considered essential for spermatogenesis. Fertility‐preserving hormonal therapy (FpHT) has been proposed to optimize hormonal milieu and improve sperm retrieval rates ...
Mattia Anfosso +5 more
wiley +1 more source
Clomiphene citrate prevents premature luteinization in stimulated intrauterine insemination cycles [PDF]
Background: Approximately 13-36% of ovarian stimulation and intrauterine insemination cycles are complicated by premature luteinizing hormone (LH) surge. Gonadotropin releasing hormone (GnRH) agonist or antagonist has been traditionally used to prevent a
Yasmin, Mahamuda +4 more
core +1 more source

